留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x

p53凋亡刺激蛋白2通过稳定β-catenin-E-cadherin复合体抑制骨肉细胞转移

郑少伟 钟浩博 缪海雄 刘伟乐 李胜发 陈楚群 孙春汉

郑少伟, 钟浩博, 缪海雄, 刘伟乐, 李胜发, 陈楚群, 孙春汉. p53凋亡刺激蛋白2通过稳定β-catenin-E-cadherin复合体抑制骨肉细胞转移[J]. 分子影像学杂志, 2017, 40(1): 40-43. doi: 10.3969/j.issn.1674-4500.2017.01.12
引用本文: 郑少伟, 钟浩博, 缪海雄, 刘伟乐, 李胜发, 陈楚群, 孙春汉. p53凋亡刺激蛋白2通过稳定β-catenin-E-cadherin复合体抑制骨肉细胞转移[J]. 分子影像学杂志, 2017, 40(1): 40-43. doi: 10.3969/j.issn.1674-4500.2017.01.12
Shaowei ZHENG, Haobo ZHONG, Haixiong MIAO, Weile LIU, Shengfa LI, Chuqun CHEN, Chunhan SUN. ASPP2 inhibits osteosarcoma cells metastasis by stabilizing the β-catenin-E-cadherin complex[J]. Journal of Molecular Imaging, 2017, 40(1): 40-43. doi: 10.3969/j.issn.1674-4500.2017.01.12
Citation: Shaowei ZHENG, Haobo ZHONG, Haixiong MIAO, Weile LIU, Shengfa LI, Chuqun CHEN, Chunhan SUN. ASPP2 inhibits osteosarcoma cells metastasis by stabilizing the β-catenin-E-cadherin complex[J]. Journal of Molecular Imaging, 2017, 40(1): 40-43. doi: 10.3969/j.issn.1674-4500.2017.01.12

p53凋亡刺激蛋白2通过稳定β-catenin-E-cadherin复合体抑制骨肉细胞转移

doi: 10.3969/j.issn.1674-4500.2017.01.12
详细信息
    作者简介:

    郑少伟,E-mail: 522948721@qq.com

ASPP2 inhibits osteosarcoma cells metastasis by stabilizing the β-catenin-E-cadherin complex

  • 摘要: 目的探讨p53凋亡刺激蛋白2(ASPP2)对骨肉瘤细胞转移的影响及其机制。方法Q-PCR检测骨肉瘤组织和细胞中ASPP2 mRNA的表达;western blot检测骨肉瘤细胞中ASPP2蛋白表达;transwell检测细胞转移能力;co-IP实验检测β-catenin和E-cadherin相互作用水平;免疫荧光检测β-catenin在细胞核中表达水平。结果8例手术标本Q-PCR检测发现,骨肉瘤组织中ASPP2 mRNA的表达较癌旁组织明显降低;4株骨肉瘤细胞系中(OS187、SAOS2、HOS和MG63)ASPP2 mRNA和蛋白的表达较正常成骨细胞明显减少。过表达ASPP2蛋白的SAOS2其转移能力明显减弱,同时β-catenin和E-cadherin相互作用水平增加,而β-catenin核转位减少。结论ASPP2可以减少骨肉瘤细胞SAOS2的转移,其机制可能的通过稳定β-catenin-E-cadherin复合体,抑制β-catenin核转位。

     

  • 图  1  骨肉瘤组织及细胞中ASPP2表达的水平

    A:Q-PCR骨肉瘤组织中ASPP2 mRNA表达水平; B: 细胞中ASPP2 mRNA表达水平; C:Western blot检测骨肉瘤细胞中ASPP2蛋白表达水平. *P<0.05 vs N; # P<0.05 vs HOSB.

    图  2  过表达ASPP2对HOS细胞侵袭的影响

    A: Western blot检测SAOS2细胞中ASPP2表达; B:Transwell实验检测SAOS2细胞侵袭能力的变化. *P<0.05 vs vector-NC.

    图  3  ASPP2对β-cantein-E-cadherin复合物稳定的影响(原放大倍数×60)

    A:CO-IP实验检测了E-cadherin和β-cantein相互作用情况; B: 免疫荧光检测β-cantein核转位,β-cantein红色荧光,DAPI蓝色荧光.

  • [1] Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance,Epidemiology, and End Results Program[J]. Cancer, 2009, 115(7):1531-43. doi: 10.1002/cncr.v115:7
    [2] Posthumadeboer J, Witlox MA, Kaspers G, et al. Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature[J]. Clin Exp Metastasis, 2011, 28(5): 493-503. doi: 10.1007/s10585-011-9384-x
    [3] Vives V, Su J, Zhong S, et al. ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth[J].Genes Dev, 2006, 20(10): 1262-7. doi: 10.1101/gad.374006
    [4] Samuels LY, O'connor DJ, Bergamaschi D, et al. ASPP proteins specifically stimulate the apoptotic function of p53[J]. Mol Cell,2001, 8(4): 781-94. doi: 10.1016/S1097-2765(01)00367-7
    [5] Wang YH, Bu FF, Royer C, et al. ASPP2 controls epithelial plasticity and inhibits metastasis through beta-catenin-dependent regulation of ZEB1[J]. Nat Cell Biol, 2014, 16(11): 1092-6. doi: 10.1038/ncb3050
    [6] 朱泳鹏, 王东军, 何友虎. 人脑胶质瘤中ASPP1和ASPP2蛋白的表达及其与细胞凋亡的相关性[J]. 广东医学, 2012, 33(13): 1964-8. http://www.cnki.com.cn/Article/CJFDTOTAL-GAYX201213049.htm
    [7] Li SJ, Shi GX, Yuan H, et al. Abnormal expression pattern of the ASPP family of proteins in human non-small cell lung cancer and regulatory functions on apoptosis through p53 by iASPP[J]. Oncol Rep, 2012, 28(1): 133-40. http://cn.bing.com/academic/profile?id=32b9feafc3c97449e7c15834935e8a06&encoded=0&v=paper_preview&mkt=zh-cn
    [8] Sgroi DC, Teng S, Robinson G, et al. In vivo gene expression profile analysis of human breast cancer progression[J]. Cancer Res,1999, 59(22): 5656-61. http://cn.bing.com/academic/profile?id=a0c1ee79a9eab9e7cac1cb48386d4c68&encoded=0&v=paper_preview&mkt=zh-cn
    [9] Meng WD, Chu RX, Wang BZ, et al. Helicobacter pylori infection and expressions of apoptosis-related proteins p53, ASPP2 and iASPP in gastric cancer and precancerous lesions[J]. Pathol Biol (Paris), 2013, 61(5): 199-202. doi: 10.1016/j.patbio.2013.02.002
    [10] 苏敏, 谷宇, 苏胜发, 等. p53凋亡刺激蛋白家族蛋白表达与非小细胞肺癌患者预后的关系[J]. 中华肿瘤杂志, 2014, 36(4): 268-72. http://cn.bing.com/academic/search?q=%e4%b8%ad%e5%8d%8e%e8%82%bf%e7%98%a4%e6%9d%82%e5%bf%97&FORM=AJOUR
    [11] Gozo MC, Jia DY, Aspuria PJ, et al. FOXC2 augments tumor propagation and metastasis in osteosarcoma[J]. Oncotarget, 2016, 7(42): 68792-802. http://cn.bing.com/academic/profile?id=aacb214b01889de1cfa8d0281fdff625&encoded=0&v=paper_preview&mkt=zh-cn
    [12] Liu HL, Zhi LQ, Duan N, et al. Abnormal expression of Tim-3 antigen on peripheral blood T cells is associated with progressive disease in osteosarcoma patients[J]. FEBS Open Bio, 2016, 6(8):807-15. doi: 10.1002/2211-5463.12079
    [13] Mak VC, Lee L, Siu MK, et al. Downregulation of ASPP2 in choriocarcinoma contributes to increased migratory potential through Src signaling pathway activation[J]. Carcinogenesis, 2013,34(9): 2170-7. doi: 10.1093/carcin/bgt161
    [14] Chang YW, Su YJ, Hsiao M, et al. Diverse targets of beta-Catenin during the Epithelial-Mesenchymal transition define cancer stem cells and predict disease relapse[J]. Cancer Res, 2015, 75(16):3398-410. doi: 10.1158/0008-5472.CAN-14-3265
    [15] Varisli L, Ozturk BE, Akyuz GK, et al. HN1 negatively influences the beta-Catenin/E-Cadherin interaction, and contributes to migration in prostate cells[J]. J Cell Biochem, 2015, 116(1): 170-8. doi: 10.1002/jcb.v116.1
    [16] Lee K, Lindsey AS, Li N, et al. Beta-catenin nuclear translocation in colorectal cancer cells is suppressed by PDE10A inhibition, cGMP elevation, and activation of PKG[J]. Oncotarget, 2016, 7(5):5353-65. http://cn.bing.com/academic/profile?id=d7c8a1c3a120ff20566b27f19f006564&encoded=0&v=paper_preview&mkt=zh-cn
    [17] Jin RS, Liu WS, Menezes S, et al. The metastasis suppressor NDRG1 modulates the phosphorylation and nuclear translocation of beta-catenin through mechanisms involving FRAT1 and PAK4 [J]. J Cell Sci, 2014, 127(14): 3116-30. doi: 10.1242/jcs.147835
  • 加载中
图(3)
计量
  • 文章访问数:  601
  • HTML全文浏览量:  269
  • PDF下载量:  4
  • 被引次数: 0
出版历程
  • 收稿日期:  2016-10-21
  • 刊出日期:  2017-01-01

目录

    /

    返回文章
    返回

    关于《分子影像学杂志》变更刊期通知

    各位专家、作者、读者:

    为了缩短出版时滞,促进科研成果的快速传播,我刊自2024年1月起,刊期由双月刊变更为月刊。本刊主要栏目有:基础研究、临床研究、技术方法、综述等。

    感谢各位专家、作者、读者长期以来对我刊的支持与厚爱!

    南方医科大学学报编辑部

    《分子影像学杂志》

    2023年12月27日